The Influence Of Obesity On Results Of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy In Locally Advanced Breast Cancer Patients

Journal Title: Polish Journal of Surgery - Year 2015, Vol 87, Issue 5

Abstract

The achieve pathologic complete response is proven to be the most important parameter of prognosis. Thereports evaluating the impact of obesity on the obtained pathologic response to chemotherapy are unequal. The aim of the study was to evaluate in locally advanced breast cancer patients, treated with AT(doxorubicin plus docetaxel) neoadjuvant chemotherapy: 1. The relationship of obesity with obtaining pathological response. 2. The relationship of obesity and free of disease recurrence survival (DFS) and overall survival (OS) associated with the tumour. Material and methods. A retrospective study was carried out in a group of 105 patients with locally advanced breast cancer, treated with AT neoadjuvant chemotherapy and then treated with radical surgery. Two variants of pathological response have been adopted: a pCR (T0N0) and pCR1 (TisN0, TxN1, T1N0, T1N1, T0N1). The relationship of obesity with pathological response and survival was investigated. Results. In univariate analysis the pCR1 was obtained with its arising from the borderline of statistical significance with lower incidence of obesity. In pCR1 multivariate analysis, negative pCR1 relationship with obesity was on the borderline of the statistical significance. The multivariate analysis showed a significant negative association OS with obesity (p=0.047) and positive with the occurrence of menopause (p = 0.029). Conclusions. In patients with locally advanced breast cancer treated with AT neoadjuvant chemotherapy.1. Obesity seems to be an independent and unfavourable predictor of the lack of obtaining pCR1 pathological response 2. In the multivariate analysis, the obesity was a significant independent factor related to shorter OS.

Authors and Affiliations

Agnieszka Karpińska, Krzysztof Safranow, Józef Kładny, Violetta Sulżyc-Bielicka

Keywords

Related Articles

Can the surgeon live his whole life? Analysis of the risk of death related to the profession

More than half of physicians in Poland are over 50 years old. This raises concerns about the risk of lack of continuity of health care services due to the generational gap, particularly marked among interventional specia...

Kariera w chirurgii naczyniowej – spojrzenie studenta

Cel: Na Oddziale Chirurgii Ogólnej i Naczyń Uniwersytetu Medycznego w Poznaniu wśród studentów rozdystrybuowano medycyny kwestionariusze w wersji papierowej i online. Celem pozyskanych w ten sposób odpowiedzi było lepsze...

Familial Adenomatous Polyposis; 30-Year Observation of a Female Patient – Case Report

Familial adenomatous polyposis (FAP) is a colorectal cancer syndrome caused by a germline mutation inherited in an autosomal-dominant pattern with a 100% penetrance. Our detailed case report presents a history of a 55-ye...

Risk Factors for Wound Dehiscence after Laparotomy – Clinical Control Trial

Inhibitory enzymu konwertazy angiotensyny odgrywają niezwykle ważną rolę w terapii chorób układu sercowo- naczyniowego. Ich skuteczność wiąże się nie tylko z działaniem hipotensyjnym, ale także z protekcyjnym wpływem na...

Download PDF file
  • EP ID EP74483
  • DOI 10.1515/pjs-2015-0047
  • Views 108
  • Downloads 0

How To Cite

Agnieszka Karpińska, Krzysztof Safranow, Józef Kładny, Violetta Sulżyc-Bielicka (2015). The Influence Of Obesity On Results Of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy In Locally Advanced Breast Cancer Patients. Polish Journal of Surgery, 87(5), 231-237. https://europub.co.uk/articles/-A-74483